GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (OTCPK:DTCFF) » Definitions » Total Debt per Share

Defence Therapeutics (Defence Therapeutics) Total Debt per Share : $0.03 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Total Debt per Share?

$0.03 (As of Mar. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Defence Therapeutics's Total Debt Per Share for the quarter that ended in Mar. 2024 was $0.03.

Defence Therapeutics Total Debt per Share Historical Data

The historical data trend for Defence Therapeutics's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Total Debt per Share Chart

Defence Therapeutics Annual Data
Trend Jun20 Jun21 Jun22
Total Debt per Share
- - -

Defence Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.03 0.03 0.03

Defence Therapeutics Total Debt per Share Calculation

Defence Therapeutics's Total Debt Per Share for the fiscal year that ended in Jun. 2022 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.00+0.00)/36.63
=0.00

Defence Therapeutics's Total Debt Per Share for the quarter that ended in Mar. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.01+1.17)/45.44
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Defence Therapeutics Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Defence Therapeutics (Defence Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (OTCPK:DTCFF) » Definitions » Total Debt per Share
Comparable Companies
TSX:EPRX NEOE:MMED TSXV:NGEN TSX:BCT TSX:ONC XCNQ:MSET TSXV:ARCH TSXV:MIR TSXV:DMT TSX:HBP OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
DTC:Germany DTC:Canada
Address
200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6
Website
https://www.defencetherapeutics.com
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.

Defence Therapeutics (Defence Therapeutics) Headlines

No Headlines